Next Science Valuation
| NXSCF Stock | USD 0.10 0.05 85.19% |
Next Science seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Next Science Limited from analyzing the firm fundamentals such as Current Valuation of 91.45 M, return on equity of -0.77, and Profit Margin of (1.12) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Next Science's price fluctuation is out of control at this time. Calculation of the real value of Next Science Limited is based on 3 months time horizon. Increasing Next Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Next pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Next Science Limited. Since Next Science is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Next Pink Sheet. However, Next Science's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.1 | Real 0.091 | Hype 0.1 | Naive 0.13 |
The real value of Next Pink Sheet, also known as its intrinsic value, is the underlying worth of Next Science Limited Company, which is reflected in its stock price. It is based on Next Science's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Next Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Next Science Limited helps investors to forecast how Next pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Next Science more accurately as focusing exclusively on Next Science's fundamentals will not take into account other important factors: About Next Science Valuation
The pink sheet valuation mechanism determines Next Science's current worth on a weekly basis. Our valuation model uses a comparative analysis of Next Science. We calculate exposure to Next Science's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Next Science's related companies.Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia. Next Science operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Next Science's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Next Science's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Next Science's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Next Science's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Next Science's revenue streams: Identify Next Science's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Next Science's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Next Science's growth potential: Evaluate Next Science's management, business model, and growth potential.
- Determine Next Science's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Next Science's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Next Science Growth Indicators
Investing in growth stocks can be very risky. If the company such as Next Science does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 198 M | |
| Forward Price Earnings | 9.1659 | |
| Retained Earnings | -50.4 M |
Complementary Tools for Next Pink Sheet analysis
When running Next Science's price analysis, check to measure Next Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Next Science is operating at the current time. Most of Next Science's value examination focuses on studying past and present price action to predict the probability of Next Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Next Science's price. Additionally, you may evaluate how the addition of Next Science to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |